Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today launched Source Document Manager
PRINCETON, N.J., April 13, 2021 /PRNewswire/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today launched Source Document Manager. This comprehensive solution enables clinical trial sponsors and contract research organizations (CROs) to collect, de-identify, translate, organize, and manage source documents seamlessly using a secure, cloud-based application. The new product generates notable efficiencies at research sites and eases global trial management in the areas of patient eligibility, routine electronic data capture (EDC), clinical adjudication, and source document verification. "The COVID-19 pandemic pushed the industry into decentralized trials and remote trial monitoring, exacerbating challenges with legacy technology and increasing the risk of noncompliance with regulatory requirements," said Dan Gebow, PhD, Chief Innovation Officer at Bioclinica. "Our solution was designed specifically to simplify the entire process of managing source documents in this environment using a single, centralized location." Bioclinica Source Document Manager supports online protected health information redaction at the site level with verification by a team of quality control experts and boasts direct integration with a premier online translation service to translate source documents. Additional features include:
Bioclinica Source Document Manager can be used as a standalone data collection and storage module to collect and review source documents online, or it can be integrated with an existing EDC system or other data tracking system to send redacted and quality-controlled source documents to their destination. About Bioclinica Bioclinica, an integrated clinical life science solutions provider, leverages knowledge and insight to minimize risk and accelerate development in clinical trials. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services, clinical endpoint adjudication, clinical trial software, and drug safety solutions. Bioclinica's global team of life science experts serves more than 500 pharmaceutical, biotechnology, and medical device organizations – including top 20 biopharmaceutical companies and leading CROs. For more information, visit www.bioclinica.com.
SOURCE Bioclinica |